Patient characteristics and medications at baseline
| HIT (n=29) | Standard care (n=37) | P | |
| Characteristic | |||
| Age of donor, years | 29 (22 to 46) | 34 (29 to 48) | 0.25 |
| Sex of donor, male | 19 (66) | 26 (70) | 0.68 |
| Cold ischaemic time, min | 205 (92 to 235) | 214 (95 to 245) | 0.56 |
| Age of recipient, years | 52 (42 to 58) | 52 (40 to 57) | 0.90 |
| Sex of recipient, male | 20 (69) | 27 (73) | 0.72 |
| LVAD | 4 (14) | 6 (16) | 0.79 |
| Reason for transplantation | 0.22 | ||
| DCM | 14 (48) | 14 (38) | |
| ICM | 9 (31) | 8 (22) | |
| Other | 6 (21) | 15 (41) | |
| Immunosuppressant | |||
| Cyclosporine | 20 (69) | 28 (76) | 0.54 |
| Tacrolimus | 9 (31) | 9 (24) | 0.54 |
| Everolimus | 10 (34) | 11 (30) | 0.68 |
| Mycophenolate | 26 (90) | 33 (89) | 1.00 |
| Prednisolone | 29 (100) | 37 (100) | 1.00 |
| Medication at baseline | |||
| Antiplatelet agents | 4 (14) | 4 (11) | 0.72 |
| Anticoagulation | 4 (14) | 2 (5) | 0.39 |
| Beta-blockers | 8 (28) | 11 (30) | 0.85 |
| ACE inhibitors | 0 (0) | 1 (3) | 1.00 |
| Angiotensin-receptor blockers | 2 (7) | 1 (3) | 0.58 |
| Statins | 28 (97) | 37 (100) | 0.44 |
| Diuretics | 25 (86) | 31 (84) | 1.00 |
Data are n (%), median (IQR), or mean±SD values. p values are for between-groups comparisons at baseline.
ACE, angiotensin-converting enzyme; DCM, dilated cardiomyopathy; HIT, high-intensity interval training; ICM, ischaemic cardiomyopathy; LVAD, left ventricular assist device.